Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_3

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

5(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 35 (100.0%)

Trials by Status

unknown120%

completed360%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

unknownphase_3

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

NCT05027295

completedphase_3

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

NCT01459679

Clinical Trials (5)

Showing 5 of 5 trials

NCT05027295Phase 3

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

Unknown

NCT00647699Phase 3

Corneal Collagen Cross-linking for Progressive Keratoconus

Completed

NCT00674661Phase 3

Corneal Collagen Cross-Linking for Ectasia (CXL)

Completed

NCT01672814Phase 3

Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus

Completed

NCT01459679Phase 3

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5